CFR /  Title 21  /  Part 314  /  Sec. 314.540 Postmarketing safety reporting.

Drug products approved under this program are subject to the postmarketing recordkeeping and safety reporting applicable to all approved drug products, as provided in Sec. Sec. 314.80 and 314.81.